Veterinary Pain Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product (Medications v/s Medical Devices), By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others), By Animal Type (Companion Animal v/s Livestock Animal), By Region and Competition
Global veterinary pain management market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing incidence of inflammatory and painful diseases such as deficiency disease, hereditary diseases, and physiological diseases in the animal population. Additionally, growing the need for easily accessible and affordable treatment procedures in urban regions and growing awareness about animal health and welfare have significantly enhanced the demand for veterinary pain management across different parts of the globe. Additionally, increasing the livestock population suffering from cancer, abdominal pain, and neuropathic pain is expected to boost the demand for different veterinary pain management, thereby fuelling the market growth through 2028. Besides, increasing research and development activities to treat various causes of pain in animals including different therapy across the globe is further expected to support the veterinary pain management market during the forecast period. According to an article published by Veterinary Practice News in June 2020, the prevalence of osteoarthritis in dogs was found to be 20% globally. Similarly, according to an article published by American Animal Health Association in April 2021, approximately 6 million dogs are diagnosed with cancer each year.
Growing Prevalence of Chronic Diseases
The increasing rate of acute and chronic diseases in animals across the globe is one of the major factors bolstering the growth of the market in the forecast period. For example, the growing incidence rate of infectious diseases such as deficiency diseases, hereditary diseases (including both genetic diseases and non-genetic hereditary diseases), and physiological diseases in animals is positively enhancing the growth of the market over the coming years. Also, due to the increasing prevalence of animal diseases which also includes epizootic diseases, there is a greater awareness and rising need for veterinary pain management therapy. Seventy percent of U.S. households, or about 90.5 million families, own a pet, according to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA). Similarly, the growing need for outpatient clinics to meet the rising volume of surgical procedures is expected to create significant growth during the forecasted period.
Increasing Investment in the Pet Healthcare Sector
Growing focus on improving the pet healthcare facilities and overall healthcare infrastructure is a major factor boosting the growth of the veterinary pain management market in the forecast period. To develop and apply new and improved technologies, there are an increasing number of strategic partnerships and collaborations with both public and private organizations. This is further expanding the diversity of market opportunities for the coming years. Additionally, the government's rising efforts to raise awareness of the value of early diagnosis are once again fuelling the market's expansion. Increasing investment in R&D, particularly in established and developing economies, about medical instruments and devices will further generate profitable market expansion prospects over the projection period. The total number of pets insured in the U.S. in 2021 was 3.9 million, a 28 percent increase since 2020. Also, the growing popularity of nonpharmaceutical pain management techniques is a major factor in the growth of the market, and the growing demand for laser therapy and electromagnetic therapy as pain management is anticipated to drive the growth of the market over the years.
Market Segmentation
Global veterinary pain management market can be segmented by product, application, animal type, and by region. Based on product, the market can be divided into Medications and Medical Devices. Based on application, the market can be differentiated into Joint Pain, Cancer Pain, Postoperative Pain, and Others. Based on application, the market can be divided into Companion Animals and Livestock animals. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East and Africa, and South America. Among the different countries, United States dominated the global veterinary pain management market on account of the growing incidence of animal diseases in the country.
Recent Development
Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Norbrook Laboratories Limited, SeQuent Scientific Limited, Merck & Co., Inc., Dechra Pharmaceuticals Plc, Vetoquinol S.A., Ceva Santй Animale SA, Chanelle Pharma Group Ltd are some of the leading players operating in the global veterinary pain management market.
Report Scope:
In this report, global veterinary pain management market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Global Veterinary Pain Management Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Growing Prevalence of Chronic Diseases
The increasing rate of acute and chronic diseases in animals across the globe is one of the major factors bolstering the growth of the market in the forecast period. For example, the growing incidence rate of infectious diseases such as deficiency diseases, hereditary diseases (including both genetic diseases and non-genetic hereditary diseases), and physiological diseases in animals is positively enhancing the growth of the market over the coming years. Also, due to the increasing prevalence of animal diseases which also includes epizootic diseases, there is a greater awareness and rising need for veterinary pain management therapy. Seventy percent of U.S. households, or about 90.5 million families, own a pet, according to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA). Similarly, the growing need for outpatient clinics to meet the rising volume of surgical procedures is expected to create significant growth during the forecasted period.
Increasing Investment in the Pet Healthcare Sector
Growing focus on improving the pet healthcare facilities and overall healthcare infrastructure is a major factor boosting the growth of the veterinary pain management market in the forecast period. To develop and apply new and improved technologies, there are an increasing number of strategic partnerships and collaborations with both public and private organizations. This is further expanding the diversity of market opportunities for the coming years. Additionally, the government's rising efforts to raise awareness of the value of early diagnosis are once again fuelling the market's expansion. Increasing investment in R&D, particularly in established and developing economies, about medical instruments and devices will further generate profitable market expansion prospects over the projection period. The total number of pets insured in the U.S. in 2021 was 3.9 million, a 28 percent increase since 2020. Also, the growing popularity of nonpharmaceutical pain management techniques is a major factor in the growth of the market, and the growing demand for laser therapy and electromagnetic therapy as pain management is anticipated to drive the growth of the market over the years.
Market Segmentation
Global veterinary pain management market can be segmented by product, application, animal type, and by region. Based on product, the market can be divided into Medications and Medical Devices. Based on application, the market can be differentiated into Joint Pain, Cancer Pain, Postoperative Pain, and Others. Based on application, the market can be divided into Companion Animals and Livestock animals. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East and Africa, and South America. Among the different countries, United States dominated the global veterinary pain management market on account of the growing incidence of animal diseases in the country.
Recent Development
- In February 2021, Dechra Pharmaceuticals PLC received rights for marketing Tri-Solfen in Australia and New Zealand under a licensing agreement with Animal Ethics Pty Ltd. Tri-Solfen is used as a routine treatment in reducing pain for farm animals.
- In July 2020, Boehringer Ingelheim acquired a Belgian biotech company, GST, to strengthen its stem cell capabilities in the Animal Health segment.
Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Norbrook Laboratories Limited, SeQuent Scientific Limited, Merck & Co., Inc., Dechra Pharmaceuticals Plc, Vetoquinol S.A., Ceva Santй Animale SA, Chanelle Pharma Group Ltd are some of the leading players operating in the global veterinary pain management market.
Report Scope:
In this report, global veterinary pain management market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Veterinary Pain Management Market, By Product:
- Medications
- Medical Devices
- Veterinary Pain Management Market, By Application:
- Joint Pain
- Cancer Pain
- Postoperative Pain
- Others
- Veterinary Pain Management Market, By Animal Type:
- Companion Animal
- Livestock Animal
- Veterinary Pain Management Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt
- Turkey
Company Profiles: Detailed analysis of the major companies present in Global Veterinary Pain Management Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL VETERINARY PAIN MANAGEMENT MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Medications v/s Medical Devices)
5.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
5.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
5.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
5.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
5.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
5.2.3.2. By Livestock Animal (Cattle, Swine, Others)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Market Map
5.3.1. By Product
5.3.2. By Application
5.3.3. By Animal Type
5.3.4. By Region
6. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Medications v/s Medical Devices)
6.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
6.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
6.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
6.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
6.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
6.2.3.2. By Livestock Animal (Cattle, Swine, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Veterinary Pain Management Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By Animal Type
6.3.2. Mexico Veterinary Pain Management Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By Animal Type
6.3.3. Canada Veterinary Pain Management Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By Animal Type
7. EUROPE VETERINARY PAIN MANAGEMENT MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Medications v/s Medical Devices)
7.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
7.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
7.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
7.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
7.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
7.2.3.2. By Livestock Animal (Cattle, Swine, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Veterinary Pain Management Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Animal Type
7.3.2. Germany Veterinary Pain Management Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Animal Type
7.3.3. United Kingdom Veterinary Pain Management Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Animal Type
7.3.4. Italy Veterinary Pain Management Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By Animal Type
7.3.5. Spain Veterinary Pain Management Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By Animal Type
8. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Medications v/s Medical Devices)
8.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
8.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
8.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
8.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
8.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
8.2.3.2. By Livestock Animal (Cattle, Swine, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Veterinary Pain Management Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Animal Type
8.3.2. India Veterinary Pain Management Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Animal Type
8.3.3. South Korea Veterinary Pain Management Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Animal Type
8.3.4. Japan Veterinary Pain Management Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Animal Type
8.3.5. Australia Veterinary Pain Management Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Animal Type
9. SOUTH AMERICA VETERINARY PAIN MANAGEMENT MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Medications v/s Medical Devices)
9.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
9.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
9.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
9.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
9.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
9.2.3.2. By Livestock Animal (Cattle, Swine, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Veterinary Pain Management Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Animal Type
9.3.2. Argentina Veterinary Pain Management Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Animal Type
9.3.3. Colombia Veterinary Pain Management Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Animal Type
10. MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Medications v/s Medical Devices)
10.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
10.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
10.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
10.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
10.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
10.2.3.2. By Livestock Animal (Cattle, Swine, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Veterinary Pain Management Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Animal Type
10.3.2. Saudi Arabia Veterinary Pain Management Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Animal Type
10.3.3. UAE Veterinary Pain Management Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Animal Type
10.3.4. Egypt Veterinary Pain Management Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product
10.3.4.2.2. By Application
10.3.4.2.3. By Animal Type
10.3.5. Turkey Veterinary Pain Management Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Product
10.3.5.2.2. By Application
10.3.5.2.3. By Animal Type
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Launches
13. COMPETITIVE LANDSCAPE
13.1. Business Overview
13.2. Product Offerings
13.3. Recent Developments
13.4. Financials (As Reported)
13.5. Key Personnel
13.6. SWOT Analysis
13.6.1. Boehringer Ingelheim International GmbH
13.6.2. Zoetis Inc.
13.6.3. Elanco Animal Health Incorporated
13.6.4. Norbrook Laboratories Limited
13.6.5. SeQuent Scientific Limited
13.6.6. Merck & Co., Inc.
13.6.7. Dechra Pharmaceuticals Plc
13.6.8. Vetoquinol S.A.
13.6.9. Ceva Santй Animale SA
13.6.10. Chanelle Pharma Group Ltd.
14. STRATEGIC RECOMMENDATIONS
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL VETERINARY PAIN MANAGEMENT MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Medications v/s Medical Devices)
5.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
5.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
5.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
5.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
5.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
5.2.3.2. By Livestock Animal (Cattle, Swine, Others)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Market Map
5.3.1. By Product
5.3.2. By Application
5.3.3. By Animal Type
5.3.4. By Region
6. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Medications v/s Medical Devices)
6.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
6.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
6.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
6.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
6.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
6.2.3.2. By Livestock Animal (Cattle, Swine, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Veterinary Pain Management Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By Animal Type
6.3.2. Mexico Veterinary Pain Management Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By Animal Type
6.3.3. Canada Veterinary Pain Management Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By Animal Type
7. EUROPE VETERINARY PAIN MANAGEMENT MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Medications v/s Medical Devices)
7.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
7.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
7.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
7.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
7.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
7.2.3.2. By Livestock Animal (Cattle, Swine, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Veterinary Pain Management Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Animal Type
7.3.2. Germany Veterinary Pain Management Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Animal Type
7.3.3. United Kingdom Veterinary Pain Management Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Animal Type
7.3.4. Italy Veterinary Pain Management Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By Animal Type
7.3.5. Spain Veterinary Pain Management Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By Animal Type
8. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Medications v/s Medical Devices)
8.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
8.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
8.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
8.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
8.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
8.2.3.2. By Livestock Animal (Cattle, Swine, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Veterinary Pain Management Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Animal Type
8.3.2. India Veterinary Pain Management Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Animal Type
8.3.3. South Korea Veterinary Pain Management Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Animal Type
8.3.4. Japan Veterinary Pain Management Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Animal Type
8.3.5. Australia Veterinary Pain Management Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Animal Type
9. SOUTH AMERICA VETERINARY PAIN MANAGEMENT MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Medications v/s Medical Devices)
9.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
9.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
9.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
9.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
9.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
9.2.3.2. By Livestock Animal (Cattle, Swine, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Veterinary Pain Management Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Animal Type
9.3.2. Argentina Veterinary Pain Management Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Animal Type
9.3.3. Colombia Veterinary Pain Management Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Animal Type
10. MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Medications v/s Medical Devices)
10.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
10.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
10.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
10.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
10.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
10.2.3.2. By Livestock Animal (Cattle, Swine, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Veterinary Pain Management Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Animal Type
10.3.2. Saudi Arabia Veterinary Pain Management Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Animal Type
10.3.3. UAE Veterinary Pain Management Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Animal Type
10.3.4. Egypt Veterinary Pain Management Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product
10.3.4.2.2. By Application
10.3.4.2.3. By Animal Type
10.3.5. Turkey Veterinary Pain Management Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Product
10.3.5.2.2. By Application
10.3.5.2.3. By Animal Type
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Launches
13. COMPETITIVE LANDSCAPE
13.1. Business Overview
13.2. Product Offerings
13.3. Recent Developments
13.4. Financials (As Reported)
13.5. Key Personnel
13.6. SWOT Analysis
13.6.1. Boehringer Ingelheim International GmbH
13.6.2. Zoetis Inc.
13.6.3. Elanco Animal Health Incorporated
13.6.4. Norbrook Laboratories Limited
13.6.5. SeQuent Scientific Limited
13.6.6. Merck & Co., Inc.
13.6.7. Dechra Pharmaceuticals Plc
13.6.8. Vetoquinol S.A.
13.6.9. Ceva Santй Animale SA
13.6.10. Chanelle Pharma Group Ltd.
14. STRATEGIC RECOMMENDATIONS
